World

Hong Kong summons UK, Australia envoys after activists granted asylum

Aug 20, 2025

Hong Kong, August 20: Two pro-democracy activists in Hong Kong have been granted asylum separately in the UK and Australia, prompting anger from the Chinese special administrative region's government.
Hong Kong summoned the Australian and British envoys, who were warned by Chief Secretary Chan Kwok-ki against "harbouring offenders".
Former lawmaker Ted Hui and student leader Tony Chung announced over the weekend that they have been granted asylum in Australia and the UK, respectively. They were sentenced to jail under a national security law that Beijing says is necessary to maintain stability in the city. However, critics say the law is being used to crush dissent and instil a climate of fear.
Hui fled Hong Kong in December 2020 while facing charges for his involvement in anti-government protests the year before. Chung left in 2023 citing an "enormous amount of stress" from constant police scrutiny.
Arrests in Hong Kong are "based on facts and evidence" and "has nothing to do with the political stance", the city's government said in a statement on Tuesday.
Hundreds of activists in Hong Kong have been arrested and charged since the sweeping national security legislation came into force in 2020, one year after widespread pro-democracy protests.
Hui said on Saturday that he and his family secured protection visas. The 43-year-old, who lives with his wife, children and parents in Adelaide, said they were forced "to leave a homeland we love and where our most precious memories remain".
Source: Qatar Tribune

More news

Niner Pharmaceuticals Expands into High-Purity Peptide Segment for Metabolic Health; Announces R&D for AI-Driven Ambientera Solution

Hyderabad (Telangana) [India], January 19: Niner Pharmaceuticals LLC has announced a major strategic expansion into the global high-purity peptide segment, shifting its focus beyond regulated supply chains to emphasize molecular innovation. The company aims to position these high-purity molecules as foundational tools for metabolic health, longevity, and recovery. In conjunction with this pharmaceutical expansion, the company has also disclosed that it is currently in the research and development phase for Ambientera, a new AI-driven home solution and residential operating system expected to launch next year.

Jan 19, 2026